|
1
|
Durmus N, Kaya T, Gültürk S, Demir T,
Parlak M and Altun A: The effects of L type calcium channels on the
electroencephalogram recordings in WAG/RIJ rat model of absence
epilepsy. Eur Rev Med Pharmacol Sci. 17:1149–1154. 2013.PubMed/NCBI
|
|
2
|
Li XW, He H, Liu YF, Gao F, Wei D, Meng
XD, Ma L and Jiang W: Effectiveness and safety assessment of
lamotrigine monotherapy for treatment of epilepsy. Eur Rev Med
Pharmacol Sci. 16:1409–1413. 2012.PubMed/NCBI
|
|
3
|
Pal A, Nayak S, Sahu PK and Swain T:
Piperine protects epilepsy associated depression: A study on role
of monoamines. Eur Rev Med Pharmacol Sci. 15:1288–1295.
2011.PubMed/NCBI
|
|
4
|
Brodie MJ: Road to refractory epilepsy:
The Glasgow story. Epilepsia. 54(Suppl 2): 5–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Berg AT, Vickrey BG, Testa FM, Levy SR,
Shinnar S, DiMario F and Smith S: How long does it take for
epilepsy to become intractable? A prospective investigation. Ann
Neurol. 60:73–79. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhen H, Zhen H and Dong Z: Definition of
drug-resistant epilepsy: Unified proposal forwarded by the project
team of International Union of Antiepileptic Treatment Strategy
Committee. Chin J Neurol. 43:487–492. 2010.
|
|
7
|
Prasad AN and Hoffmann GF: Early onset
epilepsy and inherited metabolic disorders: Diagnosis and
management. Can J Neurol Sci. 37:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Di Iorio G, Matarazzo I, Di Tizio L and
Martinotti G: Treatment-resistant insomnia treated with pregabalin.
Eur Rev Med Pharmacol Sci. 17:1552–1554. 2013.PubMed/NCBI
|
|
9
|
Wang YL, Xue F, Liu LZ and He ZH: Pathway
analysis detect potential mechanism for familial combined
hyperlipidemia. Eur Rev Med Pharmacol Sci. 17:1909–1915.
2013.PubMed/NCBI
|
|
10
|
Krysiak R and Okopie B: Chronic adrenal
failure and hypergonadotropic hypogonadism in a patient with
abetalipoproteinemia. Eur Rev Med Pharmacol Sci. 16(Suppl 4):
95–97. 2012.PubMed/NCBI
|
|
11
|
Vitiello G, De Clemente V, Della Casa R,
Romano A, Rosa M, Pascarella A, Riccitelli M, Parenti G and Del
Giudice E: Epilepsy in inherited metabolic disorders: A pediatric
series. Minerva Pediatr. 64:513–520. 2012.PubMed/NCBI
|
|
12
|
Xiaomei W, Cunming J and Yingbo Q:
Screening diagnosis and treatment progress of inherited metabolic
diseases on new born children. Inter J Gen. 35:21–24. 2012.
|
|
13
|
Kaspar H, Dettmer K, Chan Q, Daniels S,
Nimkar S, Daviglus ML, Stamler J, Elliott P and Oefner PJ: Urinary
amino acid analysis: a comparison of iTRAQ-LC-MS/MS, GC/MS, and
amino acid analyzer. J Chromatogr B Analyt Technol Biomed Life Sci.
877:1838–1846. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Padda RS, Gkouvatsos K, Guido M, Mui J,
Vali H and Pantopoulos K: A high-fat diet modulates iron metabolism
but does not promote liver fibrosis in hemochromatotic Hjv¯/¯ mice
mice. Am J Physiol Gastrointest Liver Physiol. 308:G251–G261. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakagawa K, Kawana S, Hasegawa Y and
Yamaguchi S: Simplified method for the chemical diagnosis of
organic aciduria using GC/MS. J Chromatogr B Analyt Technol Biomed
Life Sci. 878:942–948. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Campos HD: Tandem mass spectrometry as
screening for inborn errors of metabolism. Rev Med Chil.
139:1356–1364. 2011.(In Spanish). PubMed/NCBI
|
|
17
|
Yan L, Na Y and Chen F: Preliminary
analysis on 552 children with inherited metabolic disorders through
the screening of tandem mass spectrometry. Chin J Contemp Pediatr.
13:296–299. 2011.(In Chinese).
|
|
18
|
Ting A and Li L: An analysis of the
screening status of inherited metabolic disorders on high-risk
infants and young children in Xi'an in 2010. Chin J Child Care.
20:202–204. 2012.
|
|
19
|
López-Vicario C, Rius B, Alcaraz-Quiles J,
García-Alonso V, Lopategi A, Titos E and Clària J: Pro-resolving
mediators produced from EPA and DHA: Overview of the pathways
involved and their mechanisms in metabolic syndrome and related
liver diseases. Eur J Pharmacol. May 15–2015.(Epub ahead of print).
View Article : Google Scholar
|
|
20
|
Taibi-Djennah Z and Laraba-Djebari F:
Effect of cytokine antibodies in the immunomodulation of
inflammatory response and metabolic disorders induced by scorpion
venom. Int Immunopharmacol. 27:122–129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eisenstein A, Patterson S and Ravid K: The
many faces of the A2b adenosine receptor in cardiovascular and
metabolic diseases. J Cell Physiol. 230:2891–2897. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miao D and Zhang L: Leptin modulates the
expression of catabolic genes in rat nucleus pulposus cells through
the mitogen-activated protein kinase and Janus kinase 2/signal
transducer and activator of transcription 3 pathways. Mol Med Rep.
12:1761–1768. 2015.PubMed/NCBI
|
|
23
|
Johnson CW and Beckham GT: Aromatic
catabolic pathway selection for optimal production of pyruvate and
lactate from lignin. Metab Eng. 28:240–247. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Neis EP, Dejong CH and Rensen SS: The role
of microbial amino acid metabolism in host metabolism. Nutrients.
7:2930–2946. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prystupa A, Szpetnar M,
Boguszewska-Czubara A, Grzybowski A, Sak J and Załuska W: Activity
of MMP1 and MMP13 and amino acid metabolism in patients with
alcoholic liver cirrhosis. Med Sci Monit. 21:1008–1014. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Enomoto H, Aizawa N, Nakamura H, Takata R,
Sakai Y, Iwata Y, Tanaka H, Ikeda N, Aoki T, Hasegawa K, et al: A
new metabolism-related index correlates with the degree of liver
fibrosis in hepatitis C virus-positive patients. Gastroenterol Res
Pract. 2015:9261692015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Wei H, Cao J, Li Z and He P:
Metabolomics analysis of muscle from piglets fed low protein diets
supplemented with branched chain amino acids using
HPLC-high-resolution MS. Electrophoresis. 36:2250–2258. 2015.
View Article : Google Scholar
|
